Baldwin Investment Management’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $570K | Sell |
|
|||||
|
2025
Q4 | $1.01M | Buy |
|
|||||
|
2025
Q3 | $297K | Hold |
|
|||||
|
2025
Q2 | $236K | Hold |
|
|||||
|
2025
Q1 | $171K | Hold |
|
|||||
|
2024
Q4 | $270K | Hold |
|
|||||
|
2024
Q3 | $371K | Hold |
|
|||||
|
2024
Q2 | $307K | Hold |
|
|||||
|
2024
Q1 | $627K | Hold |
|
|||||
|
2023
Q4 | $272K | Hold |
|
|||||
|
2023
Q3 | $212K | Hold |
|
|||||
|
2023
Q2 | $201K | Hold |
|
|||||
|
2023
Q1 | $127K | Hold |
|
|||||
|
2022
Q4 | $56.1K | Hold |
|
|||||
|
2022
Q3 | $113 | Hold |
|
|||||
|
2022
Q2 | $82 | Hold |
|
|||||
|
2022
Q1 | $144 | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $224K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $860K | Buy |
|